Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss can be caused by cancer, treatments, or skin conditions, and trichoscopy helps diagnose it.

GLP-1 agonists may help treat certain skin conditions.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

Zinc helps manage skin disorders and deficiencies can worsen some conditions.

LED therapy is safe and shows potential for treating skin conditions and promoting hair growth, but more research is needed.

COVID-19 may be linked to hair loss or worsening of hair loss in some people.

Direct-to-consumer teledermatology is growing fast but raises concerns about quality of care and doctor-patient relationships.

COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

The complement system might be involved in the development of alopecia areata and could lead to new treatments.

The article concludes that understanding Frontal Fibrosing Alopecia (FFA) is crucial for effective treatment, which includes medication like 5α-reductase inhibitors and hydroxychloroquine.

Herbal medicine might be a good alternative for treating hair loss.

Baricitinib can help improve hair loss and skin color issues in people with Down syndrome.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

Antioxidant nanoparticles show promise for treating inflammatory diseases but need more research for safe and effective use.

Thyroid-related genes are active in skin cells and may affect autoimmune conditions.

Innate immunity genes in hair follicle stem cells might have new roles beyond traditional immune functions.

The dog with an Alopecia Areata-like condition showed signs of an autoimmune disease and partially regrew hair without treatment, suggesting dogs could be models for human AA research.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Baricitinib is a promising treatment for severe alopecia areata with minimal side effects.

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

More research is needed to understand and treat morphea effectively.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Pediatric alopecia areata needs more research to understand its characteristics and related conditions.

Exosome-based therapies show promise for treating alopecia areata but need more research.

Alopecia Areata affects people of all ages worldwide, is likely caused by genetic and environmental factors, and can lead to stress and depression, highlighting the need for treatments that address both physical and mental health.

Tiny particles called extracellular vesicles show promise for treating skin conditions and promoting hair growth.